Therefore, it is likely that the HLA-DR+ phenotype of the CD38+CD4+ T cells in IBD similarly reflects recent antigen-stimulation which warrants investigations into the antigen specificity of these cells in patients with IBD in future studies. This evidence concerns the gene CD4 and inflammatory bowel disease.